Vetter’s €210 million refinancing

Heuking Kühn Lüer Wojtek comprehensively advised Vetter on a EUR 210 million refinancing transaction. The bank consortium consists of BNP Paribas, Commerzbank, DZ BANK, Landesbank Baden-Württemberg, Landesbank Hessen-Thüringen Girozentrale, and SEB AG.

The revolving credit line has a maturity of five years, with a two-year extension option of one year each. In addition to the repayment and refinancing of existing financial liabilities, the financing purpose is the funding of the group’s general investment needs and thus the support of planned further growth in the coming years.

Vetter is a leading global pharmaceutical service provider for the development, manufacture, and packaging of aseptically pre-filled injection systems. The company is headquartered in Ravensburg and employs some 4,100 people at several German and three foreign sites in the USA (Chicago), Japan, and Singapore. In addition to small and medium-sized companies, the customer base also includes the top 10 of the world’s largest pharmaceutical and biotech companies.

Heuking Kühn Lüer Wojtek has advised Vetter with a team including Thomas K. Schrell (Picture) and Anja Harms.

Involved fees earner: Thomas Schrell – Heuking Kühn Lüer Wojtek; Anja Harms – Heuking Kühn Lüer Wojtek;

Law Firms: Heuking Kühn Lüer Wojtek;

Clients: Vetter Pharma-Fertigung GmbH & Co. KG;